Biodesix Investor Relations Material
Latest events
Q4 2023
Biodesix
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Biodesix Inc
Access all reports
Biodesix, Inc. acquires and operates diagnostic companies, as well as develops and commercializes diagnostic tests in the areas of lung cancer, malignancies, and other diseases. The company provides a multi-protein blood test, which includes Nodality gene mutational panel for use in non-small-cell lung cancer (NSCLC) patients; and Biodesix Lung Reflex testing platform that analyzes circulating tumor DNA in advanced stage NSCLC patients. Biodesix, Inc. was founded in 2002 and is based in Boulder, Colorado with additional offices in California and Germany.
Key slides for Biodesix Inc
TD Cowen 44th Annual Health Care Conference 2024
Biodesix Inc
TD Cowen 44th Annual Health Care Conference 2024
Biodesix Inc
Latest articles
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
Ticker symbol
Country
🇺🇸 United States